Mark S. Blumenkranz - May 11, 2022 Form 4 Insider Report for IVERIC bio, Inc. (ISEE)

Role
Director
Signature
/s/ Todd D.C. Anderman, as Attorney-in-Fact for Mark S. Blumenkranz
Stock symbol
ISEE
Transactions as of
May 11, 2022
Transactions value $
$0
Form type
4
Date filed
5/13/2022, 06:02 PM
Previous filing
Nov 17, 2021
Next filing
Jun 6, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ISEE Common Stock Options Exercise +7.5K +150% 12.5K May 11, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ISEE Restricted Stock Units Options Exercise $0 -7.5K -100% $0.00* 0 May 11, 2022 Common Stock 7.5K Direct F1, F2
transaction ISEE Restricted Stock Units Award $0 +14.6K $0.00 14.6K May 12, 2022 Common Stock 14.6K Direct F1, F3
transaction ISEE Stock Option (right to buy) Award $0 +23.2K $0.00 23.2K May 12, 2022 Common Stock 23.2K $9.94 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units converted into common stock on a one-for-one basis upon vesting of the units.
F2 On May 19, 2021, the Reporting Person was granted 7,500 restricted stock units, which vest in full upon on the earlier of one business day prior to the Registrant's 2022 annual meeting of stockholders or the first anniversary of the grant date.
F3 In accordance with the Registrant's Non-Employee Director Compensation Policy, the Reporting Person was granted 14,588 restricted stock units. Subject to the Reporting Person providing continued services to the Registrant and other terms and conditions under the Registrant's 2013 Stock Incentive Plan, the award of restricted stock units will vest in full on the earlier of one business day prior to the Registrant's 2023 annual meeting of stockholders or the first anniversary of the grant date. Any unvested shares subject to the award of restricted stock units will be accelerated in full upon the occurrence of a change in control event (as defined in the Registrant's 2013 Stock Incentive Plan).
F4 In accordance with the Registrant's Non-Employee Director Compensation Policy, the Reporting Person was granted a stock option to purchase 23,186 shares of the Registrant's common stock. Subject to the Reporting Person providing continued services to the Registrant and the other terms and conditions under the Registrant's 2013 Stock Incentive Plan, the stock option award will vest monthly with respect to 1/12 of the shares underlying such stock option award until the earlier of the business day immediately prior to the Registrant's 2023 annual meeting of stockholders or the first anniversary of the grant date. Any unvested shares subject to the stock option award will be accelerated in full upon the occurrence of a change in control event (as defined in the Registrant's 2013 Stock Incentive Plan).